Why is Balaxi Pharma falling/rising?

As of 12-Nov, Balaxi Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 37.91, which reflects a decrease of Rs. 2.06 or 5.15%. The stock has hit a new 52-week low today and has underperformed its sector by 5.84%. Additionally, it is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Over the past week, the stock has seen a significant drop of 11.40%, and its year-to-date performance shows a staggering decline of 47.57%. Despite a notable increase in delivery volume by 439.12% compared to the 5-day average, the overall sentiment appears negative, with no positive factors reported to counterbalance the stock's poor performance.
In the broader market context, Balaxi Pharmaceuticals' recent performance contrasts sharply with the Sensex, which has gained 1.09% over the past week and 9.44% year-to-date. This stark difference highlights the stock's struggle to keep pace with the market, as it has underperformed significantly over various time frames, including a 51.10% decline over the past year compared to the Sensex's 8.34% increase. The liquidity of the stock remains adequate for trading, but the prevailing negative sentiment and poor performance metrics suggest that investor confidence is waning, contributing to the ongoing decline in its stock price.